Indoco Remedies Share Price

ABOUT Indoco Remedies

• Industry Biotechnology & Drugs
• ISIN INE873D01024
• BSE Code 532612
• NSE Code INDOCO

Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.

MANAGEMENT

• Aditi Panandikar Chief Executive Officer, Managing Director, Executive Director
• Pramod Ghorpade Chief Financial Officer
• Ramanathan Hariharan Compliance Officer, Company Secretary, Head - Legal
• Sundeep Bambolkar Joint Managing Director, Executive Director